Home > API & Intermediate > Immune System Medication > Tofacitinib Citrate Manufacturers > Tofacitinib Citrate

Tofacitinib Citrate/Tofacitinibcitrate/CAS:540737-29-9

CAS NO.： 540737-29-9

FOB Price： NEGOTIABLE Get Latest Price

Specification： 99%; 99%

Documentation： Get COA after inquiry

Lead Time： In Stock

Max Capacity： -

Pallets Packing	20'FCL		40'FCL
Pallets Packing	With	Without	With	Without
25KG/Fibre Drum	--	20 MT	--	--
1KG/Woven Bag	--	--	--	--

Product Detail

Properties

Tofacitinib Citrate

Product introduction:

Tofacitinib citrate is a JAK kinase inhibitor for the treatment of rheumatoid arthritis. It is used for moderate to severe active rheumatoid arthritis with insufficient or intolerable response to methotrexate treatment.

CAS：540737-29-9

Molecular formula:C16H20N6O.C6H8O7

Molecular weight:504.497

Structural type:

Product purpose:Tofacitinib citrate combined with methotrexate is used to treat active rheumatoid arthritis with insufficient response to tumor necrosis factor inhibitors.

Properties

Tofatinib citrate combined with methotrexate in the treatment of active rheumatoid arthritis with insufficient response to tumor necrosis factor inhibitors.

CAS No.

540737-29-9

Formula

C22H28N6O8

Molecular Mass

504.49300

Exact Mass

504.19700

PSA

221.04000

Logp

0.23418